α2-Autoreceptors and α2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: An investigation into the α2-adrenoceptor subtypes

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 4, 1996, Pages 391-399

  Esteban, Susana ^a   Lladó, Jeròia ^a   García Sevilla, Jesús A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

2 Autoreceptors; 2 Heteroreceptors; 5 HTP serotonin synthesis; Dopa noradrenaline synthesis; Rat brain

Indexed keywords

2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; 5 HYDROXYTRYPTOPHAN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; AUTORECEPTOR; CLONIDINE; DOPA; GUANOXABENZ; LSL 61103; MIRTAZAPINE; NORADRENALIN; OXYMETAZOLINE; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; ENZYME ACTIVITY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CEREBRAL CORTEX; DIHYDROXYPHENYLALANINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HISTAMINE H1 ANTAGONISTS; IMIDAZOLES; INDOLES; ISOQUINOLINES; MALE; MIANSERIN; NOREPINEPHRINE; PIPERAZINES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 0029670213     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Adell A, Canceller A, Artigas K (1991) Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats. J Neurochem 56: 709-712
2. Andén N-E, Grabowska M, Strömbom U (1976) Different alpha-adrenoceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch Pharmacol 292:43-52
3. 2-adrenergic receptors. FASEB J 6:832-839
4. Bylund DB, Ray-Prenger C, Murphy TJ (1988) Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245:600-607
5. Bylund DB, Hass NA, Cerutis DR, Blaxall HS (1995) Characterization of alpha-2 adrenergic receptor subtypes. Pharmacol Commun 6:87-90
6. Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch Pharmacol 275: 153-168
7. Colpaert FC (1986) Maximal magnitude of effect and potency of putative α-adrenoceptor agonists in causing CNS depression, in relaxing muscle, and in lowering body temperature in rat. Drug Develop Res 7:209-220
8. 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 253:R5-R6
9. 2-adrenoceptors and their cardiovascular responses in the anaesthetized rat. Br J Pharmacol 70: 171P-172P
10. 2-Adrenoceptor modulation of brain monoamine synthesis in vivo. Methods Find Clin Pharmacol 16:P51
11. Fernstrom MH, Massoudi MS, Fernstrom JD (1990) Effect of 8-hydroxy-2-(di-N-propylamino)-tetralin on the tryptophan-induced increase in 5-hydroxytryptophan accumulation in rat brain. Life Sci 47:283-289
12. Göthert M, Schlicker E (1991) Regulation of serotonin release in the central nervous system by presynaptic heteroreceptors. In: Feigenbaum J, Hanani M (eds) Presynaptic regulation of neurotransmitter release: a handbook, vol 2. Freund, Tel Aviv, pp 845-876
13. Hancock AA, Buckner SA, Giardina WJ, Brune MH, Lee JY, Morse PA, Oheim KW, Stanisic DS, Warner RB, Kerkman DJ, DeBernardis, JF (1995) Preclinical pharmacological actions of (±)-(1′R*, 3R*)-3-phenyl-1-[(1′, 2′, 3′, 4′-tetrahydro-5′, 6′-methylenedioxy-1′-naphthalenyl)methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine. J Pharmacol Exp Ther 272:1160-1169
14. 1 recognition sites. J Recept Res 8:59-81
15. 2-adrenoceptors modulating hippocampal norepinephrine release in rat. Brain Res 674:238-244
16. 2-adrenergic receptor subtype-specific antibodies. Mol Pharmacol 43:444-450
17. 2-adrenergic receptor subtype in human spinal cord. Anesthesiology 77:983-991
18. 2 receptor classification. Mol Pharmacol 38:599-603
19. 2-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 345:410-416
20. Meller E, Goldstein M, Friedhoff AJ, Schweitzer JW (1988) N-Ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a new tool to probe CNS receptor function. Adv Exp Med Biol 235:121-136
21. 2B-adrenoceptor subtypes. Br J Pharmacol 98:890-897
22. 2-imidazoline sites in vitro and in vivo. J Neurochem 61: 1602-1610
23. 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 347:266-272
24. 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10:41-51
25. Nissbrandt H, Engberg G, Wilkström H, Magnusson T, Carlsson A (1988) NSD 1034: An amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 338:148-161
26. Nutt DJ, French N, Handley S, Hudson A, Husbands S, Jackson H, Jordan S, Lalies MD, Lewis J, Lione L, Mallard N, Pratt J (1995) Functional studies of specific imidazoline-2 receptor ligands. Ann NY Acad Sci 763:125-139
27. Ordway GA, Jaconetta SM, Halaris A (1993) Characterization of subtypes of alpha-2 adrenoceptors in the human brain. J Pharmacol Exp Ther 264:967-976
28. Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230
29. 3H] yohimbine binding in human brain. Life Sci 38:2129-2137
30. 2-Autoreceptor-mediated modulation of tyrosine hydroxylase activity in noradrenergic regions of the rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 345:653-660
31. Pinto W, Battaglia G (1994) Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B and 2A receptor subtypes in rat cortex after receptor inactivation: Evidence for differences in receptor production and degradation. Mol Pharmacol 46:1111-1119
32. 2A subtype. J Neurochem 63:1077-1085
33. 2B-subtype? Eur J Pharmacol 219:203-210
34. Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69: 864-989
35. 2-adrenoceptors: subtype determination. Pharmacol Commun 6:99-108
36. 2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 345:137-143
37. 2-autoreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 349:25-33
38. 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices. Naunyn-Schmiedeberg's Arch Pharmacol 350:473-481
39. 3H] -MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors. J Pharmacol Exp Ther 271:1558-1565
40. Vahabzadeh A, Fillenz M (1992) Studies on the origin of rat hippocampal dihydroxyphenylacetic acid using microdialysis. Neurosci Lett 136:51-55
41. 2-Adrenoceptor modulation of 5-HT biosynthesis in the rat brain. Neurosci Lett 139:53-56
42. Yoshioka M, Matsumoto M, Togashi H, Smith CB, Saito H (1992b) Effect of clonidine on the release of serotonin from the rat hippocampus as measured by microdialysis. Neurosci Lett 139:57-60
43. 2B-adrenoceptor subtypes. Pharmacol Toxicol 72:40-49
44. 2-adrenergic receptor mRNAs in the rat CNS. Mol Brain Res 10:219-225